moxifloxacin has been researched along with Infections, Staphylococcal Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanheira, M; Farrell, DJ; Jones, RN; Turner, LL | 1 |
| Citron, DM; Goldstein, EJC; Rybak, MJ; Tyrrell, KL; Warren, YA | 1 |
2 other study(ies) available for moxifloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcal Skin Infections; Staphylococcus aureus | 2012 |
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Community-Acquired Infections; Cross Infection; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Virulence; Virulence Factors | 2008 |